170 related articles for article (PubMed ID: 15772899)
1. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes.
Sougioultzoglou F; Falorni A; Kassi G; Brozzetti A; Karamitsos D; Koliakos GG
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):85-9. PubMed ID: 15772899
[TBL] [Abstract][Full Text] [Related]
2. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
3. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
Prázný M; Skrha J; Límanová Z; Hilgertová J
Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
[TBL] [Abstract][Full Text] [Related]
5. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
6. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
7. Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.
Premawardhana LD; Wijeyaratne CN; Chen S; Wijesuriya M; Illangasekera U; Brooking H; Amoroso M; Jeffreys J; Bolton J; Lazarus JH; Furmaniak J; Rees Smith B
J Endocrinol Invest; 2006 Dec; 29(11):968-74. PubMed ID: 17259793
[TBL] [Abstract][Full Text] [Related]
8. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
10. Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody.
Colman PG; Steele C; Couper JJ; Beresford SJ; Powell T; Kewming K; Pollard A; Gellert S; Tait B; Honeyman M; Harrison LC
Diabetologia; 2000 Feb; 43(2):203-9. PubMed ID: 10753042
[TBL] [Abstract][Full Text] [Related]
11. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
12. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
[TBL] [Abstract][Full Text] [Related]
13. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
14. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
16. [Auto-antibody profile and breast feeding in type 1 diabetic patients].
Pérez-Bravo F; Riesco V; Albala C; Oyarzún A; Santos JL; Carrasco E
Rev Med Chil; 2001 Jun; 129(6):611-9. PubMed ID: 11510200
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus.
Ng WY; Lee YS; Todd AL; Lui KF; Loke KY; Thai AC
Autoimmunity; 2002 Mar; 35(2):119-24. PubMed ID: 12073931
[TBL] [Abstract][Full Text] [Related]
18. Thyroid function and thyroid autoimmunity in patients with type 1 diabetes mellitus.
Radaideh A; El-Khateeb M; Batieha AM; Nasser AS; Ajlouni KM
Saudi Med J; 2003 Apr; 24(4):352-5. PubMed ID: 12754532
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
[TBL] [Abstract][Full Text] [Related]
20. [Expression of autoantibodies to ICA512 and GAD in the sera of patients with diabetic ketoacidosis or ketonemia].
Zhang YJ; Chen HL; Yu LP; Han XY
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):545-7. PubMed ID: 12516400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
